Penn State Health CEO Michael Kupferman Addresses Insurance Challenges and Innovations
Michael Kupferman, CEO of Penn State Health since June 2025, is leading the health system through challenges such as declining health insurance enrollment, the increased use of technology, and workforce shortages. Serving over two million patients across 15 counties and employing nearly 20,000 staff, the organization has focused on expanding facilities, enhancing community contributions, and revamping leadership following the departures of former CEO Steve Massini and interim CEO Deborah Addo.
The lapse of federal subsidies significantly impacts Affordable Care Act plans available through Pennie, Pennsylvania's marketplace. According to Pennie's Executive Director, Michael Trolley, average premiums have increased by 102%, resulting in about 85,000 residents discontinuing their coverage by 2026. This situation affects approximately 15,000 individuals in areas served by Penn State Health, with Lancaster County experiencing a 22% drop in plan enrollment, surpassing the state county average of 18%.
This decline in insurance coverage may lead to deferred healthcare and increased emergency room visits, thus escalating uncompensated care costs. Kupferman emphasized Penn State Health's commitment to not refusing care, yet he expressed concerns about patients potentially presenting with advanced conditions due to delayed medical attention, necessitating prolonged and costly treatment.
Kupferman noted that Penn State Health invested over $200 million in community benefits last year, which included Medicaid support, financial assistance, and various health programs. While specific strategies to address insurance-related challenges remain undefined, the institution continues to prioritize health equity initiatives such as free primary care and community nursing programs for underserved populations.
As Penn State Health expands, it has acquired the Surgery Center of Lancaster to integrate operations and address regional healthcare gaps. Kupferman aims to foster partnerships with biopharmaceutical and medical device firms to minimize patient travel for innovative treatments. The organization benefits from philanthropic efforts, including a $50 million donation from the Golisano Foundation and $18.8 million raised by Penn State University’s THON program for pediatric cancer initiatives.
Technological advancements are streamlining operations and improving patient experiences at Penn State Health. The introduction of new patient scheduling systems, ambient listening technology, and MRIs that reduce scan times are notable advancements. However, national healthcare provider shortages remain a pressing issue. Kupferman is collaborating with institutions such as Penn State University's College of Medicine to develop the healthcare workforce.
The health system is adopting Epic's electronic health record system to enhance care coordination and improve communication between patients and healthcare teams. Kupferman focuses on increasing specialist access for pediatric patients in Lancaster, highlighting the importance of local treatment availability for vulnerable populations. Neeli Bendapudi, President of Penn State University, expressed confidence in Kupferman's ability to navigate the evolving healthcare landscape, citing his clinical and administrative expertise. New to Lancaster, Kupferman appreciates his team's dedication and is committed to expanding exceptional care across the community.